The comparison of S100B between the control group and patients after head trauma (TrAlc + NonTrAlc) revealed that the serum marker level was higher in the latter group (0.092 vs. 0.99 μg/L), and the difference was statistically significant (p < 0.001) (Figure 1). This evidence concerns the gene S100B and injury.